AlphaMaven AlphaMaven

Breakingviews - COMMENTARY: Buyout barons’ forever funds have mortal flaws

Reported by Reuters
Sep 23, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Blackstone's BXPE, with about $26 billion in assets across its vehicles and inflows of roughly $1 billion a month, is the largest equity evergreen fund, while KKR's K-PEC and K-PRIME hold about $21 billion combined, according to Reuters Breakingviews.
  • • Reported US perpetual private equity assets roughly doubled from the start of 2025 to summer 2026, reaching about $100 billion per PitchBook.
  • • BXPE's 19.5% annualized return from January 2024 to June 2026 was lifted by a few private technology bets, including SpaceX, OpenAI and Anthropic, and its growth allocation rose to 24% of the portfolio by June from low single digits at launch.
  • • The Morningstar PitchBook US Private Equity Evergreen Fund Index posted an 8.4% annualized total return since May 2021 and has consistently trailed its public-market equivalent.
  • • Breakingviews flags structural risks: day-one secondary write-ups that flatter early returns, performance fees of 10% to 15% paid on unrealized valuations, and outflows likely during market stress.
Summary
Reuters Breakingviews columnist commentary argues that evergreen private equity funds, which managers including Blackstone, KKR, TPG, Carlyle and EQT have launched for both individual and institutional investors, remain an unfinished product with significant flaws. Unlike traditional closed-end funds, evergreens have no set end date and typically allow quarterly withdrawals of 3% to 5% of net asset value, with minimum commitments as low as $10,000. Equity evergreens have attracted inflows even as credit-focused equivalents face painful outflows. Partners Group, an early pioneer, suffered heavy redemptions in 2026 after poor performance.

Strategies vary widely. StepStone's $10 billion SPRING focuses on venture and growth investments including SpaceX and Databricks. KKR's K-PRIME and EQT's $2 billion Nexus lean toward traditional private equity. BXPE is a hybrid, with about 30% of its capital in deals outside the firm's closed-end vehicles. Secondary-focused evergreens such as Ares Management's $6 billion AMPF and Carlyle's $5 billion CAPM spread capital across other managers' investments. Performance is uneven: the Morningstar PitchBook index has lagged public-market equivalents, and Partners Group's flagship, AMG Pantheon's $7 billion P-PEXX and Pomona have been recent laggards. KKR and EQT vehicles have struggled to reach the low end of a 12% to 15% return goal in some older share classes.

BXPE's strong returns may not be sustainable, according to the column, because they depend on a few technology holdings that have risen sharply. Its month-on-month return for US Class I shares was just 0.4% in July, when SpaceX slid after its listing, compared with 1% to 4% over the prior six months. The column also cites accounting rules that let perpetual funds write up secondary investments, often bought at roughly a 10% discount to net asset value, to face value immediately. About 10% of historical returns at Cliffwater's Cascade Private Capital Fund stem from such day-one gains, and Apollo CEO Marc Rowan has said the practice makes "no sense."

Performance fees of 10% to 15%, sometimes paid in cash, are based largely on unrealized valuations, though clawbacks partly mitigate the risk. The column highlights KKR's use of locked-up evergreen shares as performance-fee currency as a better model. Breakingviews concludes that the industry's key test will come when investors seek to exit, since buyout assets are less liquid than short-term loans and redemptions tend to rise in hot markets and fall in crises.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Reuters Breakingviews - COMMENTARY: Buyout barons’ forever funds have mortal flaws